MSD has received US Food and Drug Administration (FDA) approval for its anti-programmed death receptor-1 (PD-1) therapy, ...

Merck & Co – known as MSD outside the US and Canada – has announced that its anti-PD-1 therapy Keytruda (pembrolizumab) has ...

The PD-L1 Inhibitors drugs uptake section examines the rate at which newly launched or upcoming potential drugs are being ...

Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...

A breast cancer patient self funding her treatment has said it's unfair she has to pay GST on the drugs that are already costing her ten of thousands of dollars. Wellington woman Amanda Broughton has ...

Merck ( MRK) is a global biopharmaceutical giant with a diversified portfolio that spans across oncology, vaccines, ...

Wellington woman Amanda Broughton will have to pay $103,000 for a course of a drug, to treat her stage 3C breast cancer. The ...

China, already gaining speed in biotechnology, is looking to further accelerate novel drug development by reducing the time ...

Teva Pharmaceutical ( NYSE: TEVA) and Shanghai Fosun Pharmaceutical announced a collaboration on Monday to develop TEV-56278, a new therapy aimed at treating various cancers through an anti-PD1-IL2 ...

Lantern Pharma (NASDAQ: LTRN) announced a remarkable clinical outcome in its Phase 2 HARMONIC(TM) trial, with a 70-year-old never-smoker with advanc ...

The recent experience of Chinese biotech companies in developing their own drug candidates and inking deals with larger ...

DelveInsight’s Anaplastic Thyroid Cancer Pipeline report depicts a robust space with 8+ active players working to develop 8+ ...